产品特点
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
TEMPORA 10 MG CHEWABLE TABLETS FOR DOGS
TEMPORA VET (NO)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains
ACTIVE SUBSTANCE:
Spironolactone ............................................................ 10 mg
EXCIPIENT(S):
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet
Oblong scored beige tablet. The tablets can be divided into equal halves
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For use in combination with standard therapy (including diuretic support, where necessary)
for the treatment of congestive heart failure caused by degenerative mitral valve disease in
dogs.
4.3
CONTRAINDICATIONS
Do not use in animals used for or intended for use in breeding.
Do not use the product in dogs suffering from hypoadrenocorticism, hyperkalaemia or
hyponatraemia.
Do not administer spironolactone in conjunction with NSAIDs to dogs with renal insufficiency.
Do not use in the case of hypersensitivity to spironolactone or any of the excipients
See section 4.7
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Kidney function and plasma potassium levels should be evaluated before initiating combined
treatment with spironolactone and ACE inhibitors. Unlike in humans, an increased incidence
of hyperkalaemia was not observed in clinical trials performed in dogs with this combination.
However, in dogs with renal impairment, regular monitoring of renal function and plasma
potassium levels is recommended
阅读完整的文件